OAKLAND, Calif - Increasing Bisphenol-A levels in urine are associated with worsening male sexual function, according to a Kaiser Permanente study appearing online in the Journal of Andrology.
Increasing urine BPA level is associated with decreased sexual desire, more difficulty having an erection, lower ejaculation strength and lower level of overall satisfaction with sex life, researchers said. The five-year study examined 427 workers in factories in China, comparing workers in BPA manufacturing facilities with a control group of workers in factories where no BPA was present.
BPA is an ingredient in manufacturing polycarbonate plastic and epoxy resins and is now contained in a wide variety of consumer products from baby bottles, plastic containers, and the resin lining of cans for food and beverages, to dental sealants. People can be exposed to BPA by using BPA-containing products.
In a previous related study, Kaiser Permanente researchers measured BPA exposure based on work history and environmental BPA exposure in the workplace (http://xnet.
"This is the first human study to show that high urine BPA is associated with lower male sexual function," said study lead author De-Kun Li, MD, PhD, a reproductive and perinatal epidemiologist at Kaiser Permanente's Division of Research in Oakland, Calif. "Also, even among men exposed to BPA from only environmental sources (no occupational exposure and with average BPA level lower than the average observed in the American population), there were indications of an increased risk of sexual dysfunction." He explained that although the estimates in the environmentally exposed group were not statistically significant due to small sample size, this finding may enhance the understanding of the BPA effect in human populations with low-dose environmental exposure and have important public health implications.
The researchers observed a dose-response association between increasing urine BPA level and declining male sexual function. The observed negative association was consistent across all categories measuring male sexual dysfunction.
This study is the second part of Kaiser Permanente's ongoing research to look at BPA's reproductive effect in humans. Both studies are the first to look at BPA's reproductive effect in humans. The adverse effect of BPA on the male reproductive system previously had been examined in animal studies only.
The study was conducted among 427 male workers in four regions of China where high levels of BPA exposure existed. These regions were chosen because there were factories where BPA or epoxy resin was manufactured. Researchers also identified workers from factories with no occupational exposure to BPA in the work environment in the same regions. Many participants provided urine samples that were tested for BPA concentration using high-performance liquid chromatography. Male sexual dysfunction levels were ascertained using standard male sexual function inventories and through in-person interviews. Through the in-person interviews, researchers also ascertained information about potential confounders including demographic characteristics, factors that may influence sexual function -- including smoking, alcohol use, chronic diseases, exposure to other chemical and heavy metals -- and occupational history.
The researchers explained that BPA is suspected from animal research to be a highly suspect human endocrine disrupter, likely affecting both male and female reproductive systems.
"Toxins in the environment contribute to diseases and health conditions. Preventing those environmental exposures requires evidence, and this study greatly enhances our understanding of the health effects of BPA," said Kathy Gerwig, Kaiser Permanente's vice president of Workplace Safety and environmental stewardship officer.
Other authors on this study include: X. Weng, PhD, J.R. Ferber, MPH, and L.J. Herrinton, PhD of the Kaiser Permanente Division of Research; Z. Zhou, PhD, MD, Y. He, PhD, and T. Wu MD, PhD of the Department of Occupational Health and Toxicology, School of Public Health & WHO Collaborating Center for Occupational Health, Fudan University, Shanghai, China; and D. Qing, M. Miao, PhD, J. Wang, PhD, Q. Zhu, MD, E. Gao, MD, MPH, PhD, and W. Yuan of Shanghai Institute of Planned Parenthood Research and National Population & Family Planning Key Laboratory of Contraceptive Drugs and Devices. The study was supported by a grant from the U.S. National Institute for Occupational Safety and Health.
About the Kaiser Permanente Division of Research (http://www.
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and the society at large. It seeks to understand the determinants of illness and well-being and to improve the quality and cost-effectiveness of health care. Currently, DOR's 500-plus staff is working on more than 250 epidemiological and health services research projects.
About Kaiser Permanente
Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve 8.6 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to: www.kp.org/newscenter.